Our Team


We create unparalleled partnerships with our clients to develop life-changing therapeutics, tests, and processes to support our mission of saving lives through enhanced patient care.

Through our expertise, customization, and scalability, NeoGenomics supports clients in cancer-related market segments, including hospital and private pathology laboratories, office-based oncologists, academic institutions, contract research and pharmaceutical development organizations, and more. We are tirelessly pushing the boundaries and improving our capabilities to provide our partners with the most technologically advanced testing available, integrating the latest clinical evidence and guidelines to advance the care of all patients.

  • Leadership
  • Board of Directors
  • Medical & Scientific
  • Scientific Advisory Board
Chris Smith profile image
Chris Smith
Chief Executive Officer
Read Bio
William Bonello
Chief Financial Officer
Read Bio
Shashikant Kulkarni profile image
Shashikant Kulkarni, MS (MEDICINE), PHD, MBA, FACMG
President of Lab Operations and Chief Scientific Officer
Read Bio
Vishal Sikri profile image
Vishal Sikri
President, Pharma Services, President and Chief Commercial Officer, Inivata
Read Bio
Kathryn B. McKenzie
Interim Chief Culture Officer, Chief Sustainability and Risk Officer
Read Bio
John Mooney
Chief Technology Officer
Read Bio
Marcus B. Silva, JD, MBA
Chief Marketing Officer
Read Bio
Hutan Hashemi
Hutan Hashemi, JD
Chief Compliance Officer
Read Bio
Ali Olivo profile image
Ali Olivo
General Counsel and Corporate Secretary
Read Bio
Steven G. Brodie, PhD FACMG
Senior Vice President, Laboratory Operations
Read Bio
Dennis Merck profile image
Dennis Merkle, PhD
Senior Vice President, Pharma Services
Read Bio